STOCK TITAN

Concorde International Group (CIGL) Financials

CIGL NASDAQ

Ticker history: YOOV became CIGL (Concorde International Group Ltd) on . Earlier news and filings retain their original names and dates. View YOOV history.

FY2025 annual
Revenue $12.5M +18.9% YoY
Net Income -$15.2M YoY not available
EPS (Diluted) -$0.67 n/m YoY
Free Cash Flow -$3.7M n/m YoY
Market Cap $44.5M as of Nov 6, 2026
Price / Sales 3.6x on $12.5M revenue, FY2025
Price / Earnings n/m net loss, so no earnings multiple, FY2025
Price / Book 12.4x on $3.6M equity, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 6, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (20-F/6-K) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD FYE December

Newest figures come from the 20-F for FY2025, filed May 12, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CIGL SEC filings page.

Concorde International Group Ltd (CIGL) reported $12.5M in revenue for fiscal year 2025, up 18.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (20-F and 6-K reports).

Rhea AI CIGL FY2025

Revenue is growing, but higher costs and expanding receivables are preventing that growth from becoming internally generated cash.

Revenue rose 17.1% between FY2023 and FY2025 while net margin moved to -122.2%, showing sales growth did not preserve profitability. FY2025 operating cash flow was -$3.5M against a net loss of $15.2M, so earnings and cash were materially disconnected through accounting and working-capital effects.

Revenue increased 18.9% in FY2025, but cost of revenue rose 25.5%, so incremental sales carried less gross profit. Gross margin fell 3.6 percentage points to 30.8%, making margin compression the clearest operating constraint rather than a simple demand slowdown.

Accounts receivable grew 31.5% while revenue grew 18.9%, suggesting more capital was tied up in customers as sales expanded. Long-term debt rose 50.0%, and financing supplied $4.2M; the balance sheet therefore supported growth partly through new external funding rather than internally generated cash.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 28 / 100
Financial Health Score 28/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Concorde International Group Ltd's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
12
Growth
60

Concorde International Group Ltd's revenue surged 18.9% year-over-year to $12.5M, reflecting rapid business expansion. This strong growth earns a score of 60/100.

Leverage
43

Concorde International Group Ltd has a moderate D/E ratio of 1.22. This balance of debt and equity financing earns a leverage score of 43/100.

Liquidity
34

Concorde International Group Ltd's current ratio of 1.28 indicates adequate short-term liquidity, earning a score of 34/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
9

Concorde International Group Ltd's operations used $3.5M of cash, and capex of $187K added to the outflow, for a free cash flow shortfall of $3.7M. This results in a cash flow score of 9/100.

Returns
9

Concorde International Group Ltd posts a -425.0% return on equity (ROE), meaning it loses $425 for every $100 of shareholders' equity. This results in a returns score of 9/100.

Piotroski F-Score Partial
3/7

Concorde International Group Ltd passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 3 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.

Earnings Quality No Cash Backing
N/A

Concorde International Group Ltd reported a net loss of $15.2M while operations used $3.5M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$12.5M
YoY+18.9%

Concorde International Group Ltd generated $12.5M in revenue in fiscal year 2025. This represents an increase of 18.9% from the prior year.

Net Income
-$15.2M

Concorde International Group Ltd reported a net loss of $15.2M in fiscal year 2025.

EPS (Diluted)
-$0.67
YoYn/m

Concorde International Group Ltd earned -$0.67 per diluted share (EPS) in fiscal year 2025. The change from the prior year is not meaningful, because that figure was zero or negative.

EBITDA

Not reported for fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
-$3.7M
YoYn/m

Concorde International Group Ltd recorded an outflow of $3.7M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. The change from the prior year is not meaningful, because that figure was zero or negative.

Cash & Debt
$1.6M
YoY+62.9%

Concorde International Group Ltd held $1.6M in cash against $4.4M in long-term debt as of fiscal year 2025.

Shares Outstanding
7M

Concorde International Group Ltd had 7M shares outstanding in fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
30.8%
YoY-3.6pp

Concorde International Group Ltd's gross margin was 30.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 3.6 percentage points from the prior year.

Return on Equity
-425.0%

Concorde International Group Ltd's ROE was -425.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.

Operating Margin

Not reported for fiscal year 2025.

Net Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

Capital Expenditures
$187K
YoY-82.2%

Concorde International Group Ltd invested $187K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 82.2% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

Share Buybacks

Not reported for fiscal year 2025.

CIGL Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CIGL annual income statement
MetricFY2520-FFY2420-FFY2320-FFY2220-F
Revenue$12.5M+18.9%$10.5M-1.6%$10.7M+112.8%$5.0M
Cost of Revenue$8.6M+25.5%$6.9M-10.3%$7.7M+110.0%$3.6M
Gross Profit$3.8M+6.4%$3.6M+20.8%$3.0M+120.5%$1.4M
Interest Expense$296K+1066.0%$25K+114.4%$12K-84.2%$75K
Income Tax$97K-15.5%$115K-12.4%$131KN/A
Net Income-$15.2MN/A$961Kn/m-$783K
EPS (Basic)-$0.67n/m-$5.08-152.9%$9.61n/m-$7.83
EPS (Diluted)-$0.67n/m-$5.08-152.9%$9.61n/m-$7.83

Not reported in any period shown, so not listed: R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Diluted Shares (Avg).

CIGL Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CIGL annual balance sheet
MetricFY2520-FFY2420-FFY2320-FFY2220-F
Total Assets$11.3M+9.7%$10.3M+20.1%$8.6MN/A
Current Assets$6.8M+26.3%$5.4M+1.7%$5.3MN/A
Cash & Equivalents$1.6M+62.9%$1.0M+4.5%$957K+116.9%$441K
Accounts Receivable$5.0M+31.5%$3.8M+9.7%$3.5MN/A
Goodwill$8K-10.9%$9K-96.9%$297K+3.6%$287K
Total Liabilities$7.6M-5.5%$8.0M+37.0%$5.8MN/A
Current Liabilities$5.3M+15.9%$4.6M+30.3%$3.5MN/A
Non-Current Liabilities$2.3M-34.2%$3.4M+47.1%$2.3MN/A
Long-Term Debt$4.4M+50.0%$2.9M+37.8%$2.1MN/A
Total Equity$3.6M+70.1%$2.1M-17.8%$2.6M+59.3%$1.6M
Retained Earnings-$98.5Mn/m-$83.3M-46997.9%$178KN/A

Not reported in any period shown, so not listed: Short-Term Investments, Inventory, Long-Term Investments.

CIGL Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CIGL annual cash flow statement
MetricFY2520-FFY2420-FFY2320-FFY2220-F
Operating Cash Flow-$3.5Mn/m-$564K-171.3%$791Kn/m-$931K
Capital Expenditures$187K-82.2%$1.1M+158.5%$407KN/A
Free Cash Flow-$3.7Mn/m-$1.6M-521.3%$384KN/A
Investing Cash Flow-$117Kn/m-$953Kn/m-$310Kn/m-$912K
Financing Cash Flow$4.2M+162.5%$1.6M+167781.2%$947-99.8%$603K

Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Dividends Paid, Share Buybacks.

CIGL Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CIGL annual financial ratios
MetricFY2520-FFY2420-FFY2320-FFY2220-F
Gross Margin30.8%-3.6pp34.5%+6.4pp28.1%+1.0pp27.1%
Net Margin-122.2%N/A9.0%+24.7pp-15.6%
Return on Equity-425.0%N/A37.5%+86.1pp-48.6%
Return on Assets-135.3%N/A11.2%N/A
Current Ratio1.28+0.1x1.17-0.3x1.50N/A
Debt-to-Equity1.22-0.2x1.38+0.6x0.82N/A
Liabilities-to-Equity2.11-1.7x3.80+1.5x2.28N/A
Asset Turnover1.11+0.1x1.02-0.2x1.25N/A
FCF Margin-29.7%-14.3pp-15.4%-19.0pp3.6%N/A

Not reported in any period shown, so not listed: Operating Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Concorde International Group Ltd CIGL FY2025 $12.5M -$15.2M N/A $44.5M 28/100
Senstar Technologies Corporation SNT FY2025 $36.4M $3.2M 8.8% $44.3M 59/100
SuperCom, Ltd SPCB FY2025 $27.9M $3.7M 13.4% $52.5M 38/100
Knightscope, Inc. KSCP FY2025 $11.3M -$33.8M N/A $11.2M 46/100
Bridger Aerospace Group Holdings, Inc. BAER FY2025 $122.8M $4.1M 3.4% $11.5M 44/100
Guardforce AI Co., Limited GFAI FY2025 $35.2M -$6.7M -18.9% $5.5M 33/100

Frequently Asked Questions

Concorde International Group Ltd (CIGL) reported $12.5M in total revenue for fiscal year 2025. This represents a 18.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Concorde International Group Ltd (CIGL) revenue grew by 18.9% year-over-year, from $10.5M to $12.5M in fiscal year 2025.

No, Concorde International Group Ltd (CIGL) reported a net loss of $15.2M in fiscal year 2025.

Concorde International Group Ltd (CIGL) reported diluted earnings per share of -$0.67 for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, Concorde International Group Ltd (CIGL) had $1.6M in cash and equivalents against $4.4M in long-term debt.

Concorde International Group Ltd (CIGL) had a gross margin of 30.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Concorde International Group Ltd (CIGL) has a return on equity of -425.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Concorde International Group Ltd (CIGL) recorded an outflow of $3.7M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Concorde International Group Ltd (CIGL) recorded an outflow of $3.5M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Concorde International Group Ltd (CIGL) had $11.3M in total assets as of fiscal year 2025, including both current and long-term assets.

Concorde International Group Ltd (CIGL) invested $187K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Concorde International Group Ltd (CIGL) had 7M shares outstanding as of fiscal year 2025.

Concorde International Group Ltd (CIGL) had a current ratio of 1.28 as of fiscal year 2025, which is considered adequate.

Concorde International Group Ltd (CIGL) had a debt-to-equity ratio of 1.22 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

Concorde International Group Ltd (CIGL) had a liabilities-to-equity ratio of 2.11 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

Concorde International Group Ltd (CIGL) had a return on assets of -135.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Concorde International Group Ltd (CIGL) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $44.5M as of Nov 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Concorde International Group Ltd (CIGL) trades at 3.6x sales, its market capitalization divided by $12.5M revenue, FY2025. The market capitalization is $44.5M as of Nov 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Concorde International Group Ltd (CIGL) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Concorde International Group Ltd (CIGL) reported a net loss of $15.2M while operations used $3.5M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Concorde International Group Ltd (CIGL) scores 28 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top